Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Tom Baker Cancer Centre (Site 0100)

Calgary, Alberta T2N 4N2, CanadaNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Bladder cancer

Closed trials

Completed
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)
NCT03924856· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Tom Baker Cancer Centre (Site 0100): trial site – Frontlight Research